Meeting the Challenges of a New Era
through Otsuka’s Venture Spirit
It has become increasingly difficult in recent years to predict socioeconomic and political changes around the world, and the future seems more and more uncertain. Even in times such as these, across our businesses we retain an unwavering commitment to our corporate philosophy—“Otsuka-people creating new products for better health worldwide” We remain focused on our mission as a global, total healthcare company, providing solutions that only Otsuka can, using approaches that go beyond the conventional.
In 2017, our pharmaceutical business proceeded on track, with the development and marketing of new drugs in and outside of Japan progressing as planned.
We also continued to diversify our product portfolio and actively invested in R&D for sustainable growth in the fields of psychiatry, neurology, oncology, and the cardiovascular and renal systems. Additionally, our digital medicine system, the first-in-the-world combination product comprised of a tablet embedded with an ingestible sensor, was approved by the US FDA, and we expect that this product will advance a new approach to medical treatment. In our nutraceuticals* business, we promote new products that meet needs that consumers themselves have not yet recognized and toward this end we continue to accelerate global development. Also in 2017, Otsuka acquired a Canadian food company as an additional pillar for our business in North America.
The year 2018 is the final one of our Second Medium-Term Management Plan. Our employees are the driving force behind our growth, and we issued the Otsuka Group Declaration on Health in April of last year to promote further progress in building work environments that make full use of people’s abilities and unique personalities. Our goal continues to be further growth to fulfill the expectations of our stakeholders. We will strive to maintain and improve the health of our employees and continue to contribute to the health of people around the world by creating new value.
We deeply appreciate your ongoing support.
President and Representative Director, CEO
- * Nutraceuticals = nutrition + pharmaceuticals